Top Biotechnology & Medical Research stocks in Australasia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
TLXTelix Pharmaceuticals	AU$5.67bn	n/a	n/a
MSBMesoblast	AU$2.85bn	n/a	n/a
PYCPYC Therapeutics	AU$2.00bn	n/a	n/a
CU6Clarity Pharmaceuticals	AU$978.44m	n/a	n/a
CGSCogstate	AU$480.35m	32.11	0.67%
RACRacura Oncology	AU$360.73m	n/a	n/a
TTXTetratherix	AU$335.71m	n/a	n/a
PEBPacific Edge	NZ$265.88m	n/a	n/a
BLSBLS Pharmaceuticals	AU$209.19m	24.32	n/a
DXBDimerix	AU$177.12m	n/a	n/a
NYRNyrada	AU$170.28m	n/a	n/a
ACWActinogen Medical	AU$145.00m	n/a	n/a
ATHAlterity Therapeutics	AU$118.54m	n/a	n/a
ILAIsland Pharmaceuticals	AU$118.38m	n/a	n/a
PTXPrescient Therapeutics	AU$90.43m	n/a	n/a
LTPLtr Pharma	AU$89.01m	n/a	n/a
PARParadigm Biopharmaceuticals	AU$77.13m	n/a	n/a
IMMImmutep	AU$76.63m	n/a	n/a
ALAArovella Therapeutics	AU$74.47m	n/a	n/a
ATXAmplia Therapeutics	AU$74.40m	n/a	n/a